Last quarter (Q3 2023), Viridian Therapeutics's total revenue was $72.00K, a decrease of -93.97% from the same quarter last year. In Q3, Viridian Therapeutics's net income was $-47.66M. See Viridian Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 249.00K	$ 1.77M	$ 2.96M	$ 1.05M	$ 4.46M	$ 8.39M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 144.00K	-	-	-	-	-
Operating Expense	$ 134.04M	$ -136.08M	$ -82.69M	$ 41.57M	$ 46.44M	$ 41.47M
Operating Income	$ -232.24M	$ -136.08M	$ -82.69M	$ -40.52M	$ -41.98M	$ -33.08M
Net Non Operating Interest Income Expense	$ 15.38M	$ 4.43M	$ 315.00K	$ -335.00K	$ 106.00K	$ 381.00K
Other Income Expense	$ -203.00K	$ -1.77M	$ -2.96M	$ -69.86M	-	-
Pretax Income	$ -216.66M	$ -129.87M	$ -79.41M	$ -110.72M	$ -41.87M	$ -32.70M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -190.97M	$ -129.87M	$ -79.41M	$ -110.72M	$ -41.87M	$ -32.70M
Basic EPS	$ -5.12	$ -4.05	$ -6.66	$ -31.13	$ -20.10	$ -16.50
Diluted EPS	$ -5.12	$ -4.05	$ -6.66	$ -31.13	$ -20.10	$ -16.50
Basic Average Shares	$ 161.24M	$ 32.09M	$ 11.92M	$ 3.56M	$ 2.09M	$ 1.97M
Diluted Average Shares	$ 161.24M	$ 32.09M	$ 11.92M	$ 3.56M	$ 2.09M	$ 1.97M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 134.04M	$ -136.08M	$ -82.69M	$ 41.57M	$ 46.44M	$ 41.47M
Net Income From Continuing And Discontinued Operation	$ -216.66M	$ -129.87M	$ -79.41M	$ -110.72M	$ -41.87M	$ -32.70M
Normalized Income	$ -81.15M	-	-	$ -40.85M	$ -41.87M	$ -32.70M
Interest Expense	-	-	-	$ 508.00K	$ 835.00K	$ 873.00K
EBIT	$ -219.34M	$ -130.37M	$ -79.41M	$ -110.21M	$ -41.04M	$ -31.83M
EBITDA	$ -170.40M	$ -130.10M	$ -78.24M	$ -109.97M	$ -40.75M	$ -31.55M

Currency in USD

Viridian Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing